Skip to content Skip to footer

International Cannabis Weekly: 31

February 9, 2018

Highlights

Share this story
Business & Investment

Highlights

Share this story
Regulation & Politics

Highlights

Share this story
Health & Science

Highlights

Share this story
Market Focus

CANNABIS CULTIVATION IN TURKEY AIMS TO COMBAT INTERNATIONAL DRUG TRAFFICKING

Sitting on the fence between the gardens of Europe and Asia, Turkey is still streets away from the more liberal drug policies of its European neighbours. The good news for now is that in an attempt to stop international narco-trafficking, Turkey has begun the process of cannabis legalisation.

This week, Prohibition Partners examines why Turkey, a historically conservative country, has legalised cannabis cultivation for research and development and what we can expect from Europe’s most eastern market.

 

 

Highlights

Share this story
Medical Cannabis in Europe - The GMP Standards Guide

Prohibition Partners is excited to announce the launch of Medical Cannabis in Europe. The GMP Standards Guide, in association with Orion GMP Solutions.

If Europe wants to become global leaders in the cannabis industry, ensuring that it adheres to the highest manufacturing practices is essential. The GMP Standards Guide is intended to be used as a reference by manufacturers, legislators and all involved in the European cannabis industry to educate on best practice and international legislation.

The report is due to be released in February 2018 but you can read a short extract here.

 

Highlights

Share this story
Cannabis Europa

 

Cannabis Europa, a conference dedicated to shaping the future of medical cannabis in Europe, will take place on 22nd May at the Barbican in London.

Enquiries on early bird tickets, speaking and sponsorship opportunities are available on the website.

Highlights

Share this story
The Europe Cannabis Report

 

Latest Issues

254

253

252

251

250

249

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.